Related references
Note: Only part of the references are listed.Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
David J. McLernon et al.
DRUG SAFETY (2010)
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
Florence van Hunsel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example
Florence van Hunsel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Consumer Reporting of Adverse Drug Reactions
Lise Aagaard et al.
DRUG SAFETY (2009)
Adverse drug reaction reporting by patients in the Netherlands - Three years of experience
Joyce de Langen et al.
DRUG SAFETY (2008)
Effect of consumer reporting on signal detection: using disproportionality analysis
Isaac W. Hammond et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience
A. Blenkinsopp et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions
EP van Puijenbroek et al.
DRUG SAFETY (2003)
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
EP van Puijenbroek et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
